At this time, TScan does not provide access to investigational products outside of clinical trials. We encourage patients to participate in clinical trials of our investigational therapies whenever possible, because clinical trials are designed, conducted, and monitored to ensure that the safety and efficacy are appropriately evaluated before they are submitted to regulatory agencies for review with the intent to make them more broadly available to patients.

You and your health care provider may learn more about our clinical trials by visiting and searching for TScan.

If you are a health care provider who is interested in learning more about one of our investigational therapies, or a physician with questions about participation in one of our clinical trials, please submit a request to The Company will acknowledge questions as soon as possible, usually within 5 business days of receipt.

TScan Therapeutics reserves the right to revise this expanded access policy at any time.